BB Biotech’s Medicines Co MDCO Stock Holding History

BB Biotech’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-302,993	Closed	-$9.32M	–	26
2013 Q2	$9.32M	Buy	+302,993	New	+$10.1M	0.67%	19

Other funds holding MDCO

SAC

Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech's MDCO Position: Q3 2013 in Review

BB Biotech sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 302,993 shares — an estimated $9.32M sold.

BB Biotech first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $9.32M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

BB Biotech reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
BB Biotech sold 302,993 Medicines Co shares in Q3 2013, an estimated $9.32M.
BB Biotech first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
BB Biotech's Medicines Co position peaked at $9.32M in Q2 2013.
172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on BB Biotech's 13F filing for Q3 2013, filed 12 Nov 2013.